• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to: 'Statistical power in "Prophylactic surfactant nebulisation for the early aeration of the preterm lung: a randomised clinical trial"'.

作者信息

Gaertner Vincent D, Bassler Dirk, Rüegger Christoph Martin

机构信息

Newborn Research Zurich, Department of Neonatology, University Hospital and University of Zurich, Zurich, Switzerland

Division of Neonatology, Dr von Hauner Children's Hospital, Ludwig Maximilians University (LMU) Munich, Munich, Germany.

出版信息

Arch Dis Child Fetal Neonatal Ed. 2023 Dec 15;109(1):113-114. doi: 10.1136/archdischild-2023-326070.

DOI:10.1136/archdischild-2023-326070
PMID:37739773
Abstract
摘要

相似文献

1
Reply to: 'Statistical power in "Prophylactic surfactant nebulisation for the early aeration of the preterm lung: a randomised clinical trial"'.回复：“预防性表面活性剂雾化用于早产儿肺早期通气：一项随机临床试验中的统计效能”
Arch Dis Child Fetal Neonatal Ed. 2023 Dec 15;109(1):113-114. doi: 10.1136/archdischild-2023-326070.
2
Statistical power in 'Prophylactic surfactant nebulisation for the early aeration of the preterm lung: a randomised clinical trial'.
Arch Dis Child Fetal Neonatal Ed. 2023 Dec 15;109(1):113. doi: 10.1136/archdischild-2023-325832.
3
Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.含蛋白质的合成表面活性剂与动物源性表面活性剂提取物用于预防和治疗呼吸窘迫综合征的比较
Cochrane Database Syst Rev. 2007 Oct 17(4):CD006069. doi: 10.1002/14651858.CD006069.pub3.
4
Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.含蛋白质的合成表面活性剂与动物源性表面活性剂提取物用于预防和治疗呼吸窘迫综合征的比较
Cochrane Database Syst Rev. 2007 Jul 18(3):CD006069. doi: 10.1002/14651858.CD006069.pub2.
5
Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.表面活性物质治疗在有呼吸窘迫综合征风险的早产儿中根据肺成熟度检测指导。
Cochrane Database Syst Rev. 2023 Oct 26;10(10):CD013158. doi: 10.1002/14651858.CD013158.pub2.
6
Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.含蛋白质的合成表面活性剂与不含蛋白质的合成表面活性剂用于预防和治疗呼吸窘迫综合征的比较
Cochrane Database Syst Rev. 2009 Oct 7(4):CD006180. doi: 10.1002/14651858.CD006180.pub2.
7
Prophylactic Oropharyngeal Surfactant for Preterm Newborns at Birth: A Randomized Clinical Trial.出生时给早产新生儿预防性使用口咽表面活性剂：一项随机临床试验
JAMA Pediatr. 2024 Feb 1;178(2):117-124. doi: 10.1001/jamapediatrics.2023.5082.
8
Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.预防性合成表面活性剂用于预防早产儿发病和死亡。
Cochrane Database Syst Rev. 2000(2):CD001079. doi: 10.1002/14651858.CD001079.
9
Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants.用于预防早产儿发病和死亡的预防性无蛋白合成表面活性剂。
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD001079. doi: 10.1002/14651858.CD001079.pub2.
10
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.早期与延迟选择性表面活性剂治疗新生儿呼吸窘迫综合征
Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD001456. doi: 10.1002/14651858.CD001456.pub2.